Skip to main content
OBIO
NASDAQ Industrial Applications And Services

Institutional Investor RTW Investments Increases Potential Stake in Orchestra BioMed to 19.7%

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Neutral
Importance info
7
Price
$4.35
Mkt Cap
$245.622M
52W Low
$2.2
52W High
$5.424
52W Position info
98% above low
Off High info
20% below high
Rel. Volume info
0.9× avg
Market data snapshot near publication time

OBIO sits 98% above its 52-week low of $2.2.

Summary

RTW Investments increased the maximum exercisability of its pre-funded warrants, leading to a deemed beneficial ownership of 19.7% of Orchestra BioMed, including an additional 3.6 million shares.


Key Events · Ownership and Investor Activity · OBIO

  • Increased Warrant Exercisability

    RTW Funds submitted notices to the Issuer increasing the Maximum Percentage under their Pre-Funded Warrants from 9.99% to 19.99%.

  • Significant Deemed Ownership Increase

    This adjustment results in the Reporting Persons being deemed to beneficially own an additional 3,636,363 shares of common stock.

  • Total Beneficial Ownership

    RTW Investments, LP and its affiliates now beneficially own 11,942,426 shares, representing 19.7% of the outstanding common stock.

  • No Recent Transactions

    The filing explicitly states that none of the Reporting Persons have effected any transactions with respect to the Issuer's securities during the past sixty days.


Analysis · OBIO · Industrial Applications And Services

RTW Investments, a significant institutional holder, amended its Schedule 13D to reflect an increase in the maximum percentage for its pre-funded warrants from 9.99% to 19.99%. This technical adjustment allows RTW to be deemed to beneficially own an additional 3.6 million shares, bringing their total potential beneficial ownership to 19.7% of Orchestra BioMed. While not an immediate share purchase, this move indicates RTW's continued flexibility and potential to increase its stake in the company, signaling ongoing interest from a major investor.

How filings like this one have moved

In the 30 days to Nov 15, 2026, 37.5% of the 3713 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, OBIO was trading at $4.35 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $245.6M. The 52-week trading range was $2.20 to $5.42. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

OBIO - Latest Insights

OBIO
Nov 12, 2026, 4:27 PM EST
Filing Type: 4
Importance Score:
7
Price at Filing: $6.23
Real-time Price: $7.29 info
Change: +$1.06 (+17%) info
Market Cap: $560.379M info
OBIO
Nov 10, 2026, 4:04 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $5.73
Real-time Price: $7.29 info
Change: +$1.56 (+27%) info
Market Cap: $560.379M info
OBIO
Nov 06, 2026, 5:11 PM EST
Filing Type: 424B5
Importance Score:
8
Price at Filing: $5.68
Real-time Price: $7.29 info
Change: +$1.61 (+28%) info
Market Cap: $560.379M info
OBIO
Nov 05, 2026, 10:43 PM EST
Source: Reuters
Importance Score:
7
Price at Filing: $5.00
Real-time Price: $7.29 info
Change: +$2.29 (+46%) info
Market Cap: $560.379M info
OBIO
Nov 05, 2026, 4:01 PM EST
Filing Type: 424B5
Importance Score:
7
Price at Filing: $5.56
Real-time Price: $7.29 info
Change: +$1.73 (+31%) info
Market Cap: $560.379M info